Shell Companies
Compare Stocks
5 / 10Stock Comparison
HYAC vs LAZ vs EVR vs MC vs HLI
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
Financial - Capital Markets
Financial - Capital Markets
Financial - Capital Markets
HYAC vs LAZ vs EVR vs MC vs HLI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Shell Companies | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets |
| Market Cap | $318M | $4.36B | $13.11B | $4.69B | $10.71B |
| Revenue (TTM) | $197M | $3.19B | $3.88B | $1.52B | $2.39B |
| Net Income (TTM) | $15M | $237M | $592M | $233M | $448M |
| Gross Margin | 70.5% | 31.8% | 99.4% | 99.2% | 38.5% |
| Operating Margin | -0.5% | 13.0% | 20.5% | 18.1% | 21.0% |
| Forward P/E | 28.3x | 16.2x | 17.8x | 21.1x | 19.8x |
| Total Debt | $400K | $2.58B | $1.16B | $267M | $438M |
| Cash & Equiv. | $101K | $1.50B | $1.47B | $509M | $971M |
HYAC vs LAZ vs EVR vs MC vs HLI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 23 | Apr 26 | Return |
|---|---|---|---|
| Haymaker Acquisitio… (HYAC) | 100 | 105.7 | +5.7% |
| Lazard Ltd (LAZ) | 100 | 137.0 | +37.0% |
| Evercore Inc. (EVR) | 100 | 216.5 | +116.5% |
| Moelis & Company (MC) | 100 | 126.3 | +26.3% |
| Houlihan Lokey, Inc. (HLI) | 100 | 134.1 | +34.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HYAC vs LAZ vs EVR vs MC vs HLI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HYAC carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta 0.03, Low D/E 0.2%, current ratio 0.36x
- Efficiency ratio 0.0% vs MC's 0.8% (lower = leaner)
- Beta 0.03 vs EVR's 1.90, lower leverage
- Efficiency ratio 0.0% vs MC's 0.8%
LAZ ranks third and is worth considering specifically for value.
- Lower P/E (16.2x vs 21.1x)
EVR is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 29.5%, EPS growth 54.7%
- 6.1% 10Y total return vs HLI's 6.0%
- 29.5% NII/revenue growth vs HYAC's -145.0%
- +60.9% vs HLI's -5.1%
MC is the clearest fit if your priority is defensive.
- Beta 1.75, yield 4.1%, current ratio 21.47x
- 4.1% yield, 1-year raise streak, vs HLI's 1.6%, (1 stock pays no dividend)
HLI is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 7 yrs, beta 0.94, yield 1.6%
- PEG 1.26 vs EVR's 1.57
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 29.5% NII/revenue growth vs HYAC's -145.0% | |
| Value | Lower P/E (16.2x vs 21.1x) | |
| Quality / Margins | Efficiency ratio 0.0% vs MC's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 0.03 vs EVR's 1.90, lower leverage | |
| Dividends | 4.1% yield, 1-year raise streak, vs HLI's 1.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +60.9% vs HLI's -5.1% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs MC's 0.8% |
HYAC vs LAZ vs EVR vs MC vs HLI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
HYAC vs LAZ vs EVR vs MC vs HLI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HLI leads in 1 of 6 categories
LAZ leads 1 • MC leads 1 • EVR leads 1 • HYAC leads 1 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HLI leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
EVR is the larger business by revenue, generating $3.9B annually — 19.7x HYAC's $197M. HLI is the more profitable business, keeping 16.7% of every revenue dollar as net income compared to HYAC's 5.7%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $197M | $3.2B | $3.9B | $1.5B | $2.4B |
| EBITDAEarnings before interest/tax | $8M | $384M | $804M | $286M | $591M |
| Net IncomeAfter-tax profit | $15M | $237M | $592M | $233M | $448M |
| Free Cash FlowCash after capex | $29M | $519M | $1.2B | $540M | $739M |
| Gross MarginGross profit ÷ Revenue | +70.5% | +31.8% | +99.4% | +99.2% | +38.5% |
| Operating MarginEBIT ÷ Revenue | -0.5% | +13.0% | +20.5% | +18.1% | +21.0% |
| Net MarginNet income ÷ Revenue | +5.7% | +7.4% | +15.3% | +15.4% | +16.7% |
| FCF MarginFCF ÷ Revenue | -0.2% | +15.9% | +30.5% | +35.6% | +33.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +115.6% | -43.8% | +44.2% | -4.3% | +22.3% |
Valuation Metrics
LAZ leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 21.4x trailing earnings, LAZ trades at a 24% valuation discount to HYAC's 28.3x P/E. Adjusting for growth (PEG ratio), HLI offers better value at 1.67x vs EVR's 2.08x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $318M | $4.4B | $13.1B | $4.7B | $10.7B |
| Enterprise ValueMkt cap + debt − cash | $318M | $5.4B | $12.8B | $4.5B | $10.2B |
| Trailing P/EPrice ÷ TTM EPS | 28.29x | 21.40x | 23.56x | 21.74x | 26.37x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.18x | 17.78x | 21.09x | 19.85x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.08x | — | 1.67x |
| EV / EBITDAEnterprise value multiple | — | 12.09x | 15.91x | 15.58x | 18.75x |
| Price / SalesMarket cap ÷ Revenue | 1.61x | 1.37x | 3.38x | 3.09x | 4.48x |
| Price / BookPrice ÷ Book value/share | 1.32x | 4.99x | 6.33x | 7.44x | 4.84x |
| Price / FCFMarket cap ÷ FCF | — | 8.63x | 11.09x | 8.69x | 13.24x |
Profitability & Efficiency
MC leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MC delivers a 37.9% return on equity — every $100 of shareholder capital generates $38 in annual profit, vs $5 for HYAC. HYAC carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to LAZ's 2.61x. On the Piotroski fundamental quality scale (0–9), HLI scores 7/9 vs LAZ's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.8% | +26.7% | +29.3% | +37.9% | +20.1% |
| ROA (TTM)Return on assets | +13.9% | +5.2% | +14.1% | +15.9% | +11.9% |
| ROICReturn on invested capital | -0.3% | +9.5% | +18.8% | +24.9% | +15.5% |
| ROCEReturn on capital employed | -0.4% | +9.5% | +17.6% | +22.0% | +20.1% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 6 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.00x | 2.61x | 0.50x | 0.39x | 0.20x |
| Net DebtTotal debt minus cash | $298,874 | $1.1B | -$311M | -$241M | -$533M |
| Cash & Equiv.Liquid assets | $101,126 | $1.5B | $1.5B | $509M | $971M |
| Total DebtShort + long-term debt | $400,000 | $2.6B | $1.2B | $267M | $438M |
| Interest CoverageEBIT ÷ Interest expense | -0.47x | 4.74x | 32.72x | — | — |
Total Returns (Dividends Reinvested)
EVR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HLI five years ago would be worth $24,153 today (with dividends reinvested), compared to $10,570 for HYAC. Over the past 12 months, EVR leads with a +60.9% total return vs HLI's -5.1%. The 3-year compound annual growth rate (CAGR) favors EVR at 46.8% vs HYAC's 1.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -5.7% | -5.6% | -5.5% | -9.4% | -12.6% |
| 1-Year ReturnPast 12 months | -2.7% | +17.8% | +60.9% | +24.4% | -5.1% |
| 3-Year ReturnCumulative with dividends | +5.7% | +80.2% | +216.3% | +104.0% | +85.7% |
| 5-Year ReturnCumulative with dividends | +5.7% | +20.6% | +136.2% | +50.2% | +141.5% |
| 10-Year ReturnCumulative with dividends | +5.7% | +100.4% | +613.3% | +262.4% | +603.4% |
| CAGR (3Y)Annualised 3-year return | +1.9% | +21.7% | +46.8% | +26.8% | +22.9% |
Risk & Volatility
HYAC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HYAC is the less volatile stock with a 0.03 beta — it tends to amplify market swings less than EVR's 1.90 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HYAC currently trades 85.7% from its 52-week high vs HLI's 72.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.03x | 1.78x | 1.88x | 1.72x | 0.87x |
| 52-Week HighHighest price in past year | $12.54 | $58.75 | $388.71 | $78.22 | $211.78 |
| 52-Week LowLowest price in past year | $9.67 | $38.67 | $206.63 | $51.06 | $134.41 |
| % of 52W HighCurrent price vs 52-week peak | +85.7% | +79.0% | +85.2% | +81.7% | +72.5% |
| RSI (14)Momentum oscillator 0–100 | 15.2 | 50.9 | 53.0 | 49.1 | 36.6 |
| Avg Volume (50D)Average daily shares traded | 245K | 1.5M | 622K | 1.3M | 606K |
Analyst Outlook
Evenly matched — MC and HLI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HYAC as "Buy", LAZ as "Buy", EVR as "Buy", MC as "Hold", HLI as "Buy". Consensus price targets imply 22.5% upside for HLI (target: $188) vs 4.4% for LAZ (target: $49). For income investors, MC offers the higher dividend yield at 4.12% vs EVR's 0.98%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $48.50 | $382.67 | $73.40 | $188.00 |
| # AnalystsCovering analysts | 2 | 29 | 21 | 22 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | +3.8% | +1.0% | +4.1% | +1.6% |
| Dividend StreakConsecutive years of raises | — | 1 | 0 | 1 | 7 |
| Dividend / ShareAnnual DPS | — | $1.75 | $3.25 | $2.63 | $2.41 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.1% | +5.0% | +1.6% | +0.5% |
HLI leads in 1 of 6 categories (Income & Cash Flow). LAZ leads in 1 (Valuation Metrics). 1 tied.
HYAC vs LAZ vs EVR vs MC vs HLI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HYAC or LAZ or EVR or MC or HLI a better buy right now?
For growth investors, Evercore Inc.
(EVR) is the stronger pick with 29. 5% revenue growth year-over-year, versus 3. 2% for Lazard Ltd (LAZ). Lazard Ltd (LAZ) offers the better valuation at 21. 4x trailing P/E (16. 2x forward), making it the more compelling value choice. Analysts rate Haymaker Acquisition Corp. III (HYAC) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HYAC or LAZ or EVR or MC or HLI?
On trailing P/E, Lazard Ltd (LAZ) is the cheapest at 21.
4x versus Haymaker Acquisition Corp. III at 28. 3x. On forward P/E, Lazard Ltd is actually cheaper at 16. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Houlihan Lokey, Inc. wins at 1. 26x versus Evercore Inc. 's 1. 57x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — HYAC or LAZ or EVR or MC or HLI?
Over the past 5 years, Houlihan Lokey, Inc.
(HLI) delivered a total return of +141. 5%, compared to +5. 7% for Haymaker Acquisition Corp. III (HYAC). Over 10 years, the gap is even starker: EVR returned +633. 6% versus HYAC's +5. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HYAC or LAZ or EVR or MC or HLI?
By beta (market sensitivity over 5 years), Haymaker Acquisition Corp.
III (HYAC) is the lower-risk stock at 0. 03β versus Evercore Inc. 's 1. 88β — meaning EVR is approximately 7153% more volatile than HYAC relative to the S&P 500. On balance sheet safety, Haymaker Acquisition Corp. III (HYAC) carries a lower debt/equity ratio of 0% versus 3% for Lazard Ltd — giving it more financial flexibility in a downturn.
05Which is growing faster — HYAC or LAZ or EVR or MC or HLI?
By revenue growth (latest reported year), Evercore Inc.
(EVR) is pulling ahead at 29. 5% versus 3. 2% for Lazard Ltd (LAZ). On earnings-per-share growth, the picture is similar: Haymaker Acquisition Corp. III grew EPS 137. 5% year-over-year, compared to -19. 0% for Lazard Ltd. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HYAC or LAZ or EVR or MC or HLI?
Houlihan Lokey, Inc.
(HLI) is the more profitable company, earning 16. 7% net margin versus 5. 7% for Haymaker Acquisition Corp. III — meaning it keeps 16. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLI leads at 21. 0% versus -0. 5% for HYAC. At the gross margin level — before operating expenses — EVR leads at 99. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HYAC or LAZ or EVR or MC or HLI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Houlihan Lokey, Inc. (HLI) is the more undervalued stock at a PEG of 1. 26x versus Evercore Inc. 's 1. 57x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Lazard Ltd (LAZ) trades at 16. 2x forward P/E versus 21. 1x for Moelis & Company — 4. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLI: 22. 5% to $188. 00.
08Which pays a better dividend — HYAC or LAZ or EVR or MC or HLI?
In this comparison, MC (4.
1% yield), LAZ (3. 8% yield), HLI (1. 6% yield), EVR (1. 0% yield) pay a dividend. HYAC does not pay a meaningful dividend and should not be held primarily for income.
09Is HYAC or LAZ or EVR or MC or HLI better for a retirement portfolio?
For long-horizon retirement investors, Houlihan Lokey, Inc.
(HLI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 1. 6% yield, +601. 0% 10Y return). Lazard Ltd (LAZ) carries a higher beta of 1. 78 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HLI: +601. 0%, LAZ: +105. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HYAC and LAZ and EVR and MC and HLI?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HYAC is a small-cap quality compounder stock; LAZ is a small-cap income-oriented stock; EVR is a mid-cap high-growth stock; MC is a small-cap high-growth stock; HLI is a mid-cap high-growth stock. LAZ, EVR, MC, HLI pay a dividend while HYAC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.